Severe transient myocardial ischaemia caused by hypertrophic cardiomyopathy in a patient with congenital disorder of glycosylation type Ia

Eur J Pediatr. 2002 Oct;161(10):524-7. doi: 10.1007/s00431-002-1029-2. Epub 2002 Aug 22.

Abstract

Severely affected children with congenital disorder of glycosylation type Ia (CDG-Ia; MIM 212065) may develop hypertrophic cardiomyopathy. In this report we describe the near-death of a 10-month-old girl with CDG-Ia due to acute left-ventricular outlet obstruction caused by hypertrophic cardiomyopathy and acute dehydration. The girl had multi-organ failure and signs of severe myocardial damage mimicking myocardial infarction.

Conclusion: hypertrophic cardiomyopathy contributes to the high mortality of young children with congenital disorder of glycosylation type Ia. Even if cardiomyopathy in this disease is non-obstructive, acute fluid-loss might cause left ventricular outflow tract obstruction and life-threatening myocardial ischaemia. Patients with congenital disorder of glycosylation type Ia are at risk for cardiac complications and should be monitored regularly by echocardiography.

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Cardiomyopathy, Hypertrophic / complications*
  • Cardiomyopathy, Hypertrophic / congenital*
  • Cardiomyopathy, Hypertrophic / enzymology
  • Congenital Disorders of Glycosylation / complications
  • Congenital Disorders of Glycosylation / enzymology
  • Electrocardiography
  • Female
  • Glycosylation
  • Heart Defects, Congenital / enzymology
  • Heart Defects, Congenital / etiology
  • Humans
  • Infant
  • Myocardial Ischemia / enzymology
  • Myocardial Ischemia / etiology*
  • Phosphotransferases (Phosphomutases) / deficiency
  • Severity of Illness Index
  • Ventricular Outflow Obstruction / enzymology
  • Ventricular Outflow Obstruction / etiology

Substances

  • Phosphotransferases (Phosphomutases)
  • phosphomannomutase